GeoVax raises ~$3.1M gross in offering of stock, pre-funded and common warrants

GeoVax Labs, Inc.

Offering of 1,085,000 shares (or equivalents) at $2.86; pre-funded warrants for 626,368 shares and common warrants for 2,170,000 shares.
Net proceeds ~$2.836M after fees; use for working capital and general corporate purposes.
Warrants exercisable post-stockholder approval at $2.86 per share, five-year term; lock-up provisions for 38 days.
Closing expected July 12, 2024; Roth Capital Partners acted as placement agent with 7.0% cash fee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.